JAZZ
JAZZ PHARMACEUTICALS PLCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
JAZZ PHARMACEUTICALS PLC (JAZZ) is held as common stock by 4 tracked hedge-fund managers, with a combined reported value of ~$589.09M; the largest are Ken Griffin, Izzy Englander, Renaissance Technologies. 2 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 1 added, 3 trimmed, 1 closed. 7 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Cooling
Common-stock holders42 also report options
Congress trades7
Price$232.35vs quarter-end-3.58%
Sectors0
This quarter's moves
Top holderNew0
Added1
Trimmed / sold4
Ken GriffinCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $11.25M— of portfolio46,7002026 Q2
Value $7.78M— of portfolio32,3002026 Q2
Value $1.76M— of portfolio7,3002026 Q2
Value $192.8K— of portfolio8002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $11.25M | — | — |
| Ken GriffinPUT | $7.78M | — | — |
| Steven CohenPUT | $1.76M | — | — |
| Steven CohenCALL | $192.8K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.